-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Aardvark Therapeutics, Maintains $26 Price Target

Benzinga·02/10/2026 17:41:59
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Aardvark Therapeutics (NASDAQ:AARD) with a Buy and maintains $26 price target.